Literature DB >> 18987625

Perspective: Translational studies on glutamate and dopamine neurocircuitry in addictions: implications for addiction treatment.

Evelyn K Lambe, Tony P George.   

Abstract

New research suggests that the modulation of dopamine neurocircuitry by glutamate plays a key role in the development of nicotine and other addictions. For example, manipulation of glutamatergic pathways can alter the mood-enhancing and reinforcing properties of nicotine. These glutamatergic pathways are also sensitive to manipulation by other drugs of abuse. The studies described in this special issue of Neuropsychopharmacology bring together rodent studies with translational work in humans to enhance our understanding of the cellular mechanisms underlying the subjective and objective effects of drugs of abuse. These studies suggest new therapeutic targets based on central glutamate systems that may lead to the development of novel and more effective treatments for addictive disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987625      PMCID: PMC4644073          DOI: 10.1038/npp.2008.196

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  12 in total

1.  Differential involvement of glutamatergic mechanisms in the cognitive and subjective effects of smoking.

Authors:  A Jackson; J Nesic; C Groombridge; O Clowry; J Rusted; T Duka
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

2.  The Reward Signal of Midbrain Dopamine Neurons.

Authors:  Wolfram Schultz
Journal:  News Physiol Sci       Date:  1999-12

3.  Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice.

Authors:  Yann S Mineur; Oli Somenzi; Marina R Picciotto
Journal:  Neuropharmacology       Date:  2007-01-20       Impact factor: 5.250

4.  Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.

Authors:  Arthur L Brody; Mark A Mandelkern; Richard E Olmstead; Zoe Allen-Martinez; David Scheibal; Anna L Abrams; Matthew R Costello; Judah Farahi; Sanjaya Saxena; John Monterosso; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2008-06-18       Impact factor: 7.853

5.  Long-lasting cognitive deficits resulting from adolescent nicotine exposure in rats.

Authors:  Danielle S Counotte; Sabine Spijker; Linda H Van de Burgwal; François Hogenboom; Anton N M Schoffelmeer; Taco J De Vries; August B Smit; Tommy Pattij
Journal:  Neuropsychopharmacology       Date:  2008-06-25       Impact factor: 7.853

6.  Topiramate for treating alcohol dependence: a randomized controlled trial.

Authors:  Bankole A Johnson; Norman Rosenthal; Julie A Capece; Frank Wiegand; Lian Mao; Karen Beyers; Amy McKay; Nassima Ait-Daoud; Raymond F Anton; Domenic A Ciraulo; Henry R Kranzler; Karl Mann; Stephanie S O'Malley; Robert M Swift
Journal:  JAMA       Date:  2007-10-10       Impact factor: 56.272

7.  Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.

Authors:  Robert M Anthenelli; Thomas J Blom; Susan L McElroy; Paul E Keck
Journal:  Addiction       Date:  2008-04       Impact factor: 6.526

8.  Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study.

Authors:  Tony P George; Kristi A Sacco; Jennifer C Vessicchio; Andrea H Weinberger; R Douglas Shytle
Journal:  J Clin Psychopharmacol       Date:  2008-06       Impact factor: 3.153

9.  NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala.

Authors:  Paul J Kenny; Elena Chartoff; Marisa Roberto; William A Carlezon; Athina Markou
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

10.  Is cocaine desire reduced by N-acetylcysteine?

Authors:  Steven D LaRowe; Hugh Myrick; Sarra Hedden; Pascale Mardikian; Michael Saladin; Aimee McRae; Kathleen Brady; Peter W Kalivas; Robert Malcolm
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.